Sanguine Biosciences (United States)
- Research works
- 1 ▼ 29% vs 2013–17
- Citations
- 271 189.5 per fractional work
- Top-10% rate
- 35.9% record average 16.5%
- Open access
- 24% world 28%
Not ranked overall: Sanguine Biosciences (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Sanguine Biosciences (United States) publish most on?
By volume in 2022–2025: Iron Metabolism and Disorders, Hemoglobinopathies and Related Disorders, Reproductive System and Pregnancy and Lymphoma Diagnosis and Treatment.
- 1 Iron Metabolism and Disorders Hematology 0 works
- 2 Hemoglobinopathies and Related Disorders Genetics 0 works
- 3 Reproductive System and Pregnancy Immunology 0 works
- 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 5 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Sanguine Biosciences (United States)'s research output changed?
Output in 2018–2022 was 29% lower than in 2013–2017.
Other research institutions in Sherman Oaks
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.